FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Breaking: Tiger Woods Involved in Rollover Crash in Florida

Rubio Accuses Zelenskyy of Telling a Significant Lie About US Security Guarantees: ‘He Knows That’s Not True’

Driver passed out as self-driving car kept moving—police find more than a medical emergency inside

Johnson accuses Democrats of taking government hostage over ‘crazy’ immigration agenda

Mamdani endorses planned NYC ‘No Kings’ rally, derides ICE as ‘rogue agency’

Secret Service Agent Shoots Himself While Working on Jill Biden’s Detail

Fox News True Crime Newsletter: ‘Lovers’ Lane’ breakthrough, Gilgo Beach suspect’s plea, Jimmy Gracey’s ruling

Mike Johnson splits from Thune with eight-week DHS funding bill

Hollywood Star Sounds Off About Celeb Politics: You Make ‘Half Your Audience Despise You’

Trump will ask Congress to pass additional farm relief amid Iran war price spikes

Judge freezes Trump admin move against AI firm, fueling battle over security authority

Greg Bovino is writing a book to ‘memorialize’ the Border Patrol officers on the front lines of Trump’s deportation operation

‘Ship has sailed’: This is what Dems won’t get in DHS deal after shunning GOP

Watch: Trump Roasts Fox News Polls While Live on the Network, Calls for Co-Host’s Removal

Hackers tied to Iran breach FBI director’s personal email and post private images

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”